NewsAI-assisted

PacBio Launches SPRQ-Nx Chemistry on Vega Benchtop System with 21 CFR Part 11 Audit Logging

PacBio ships SPRQ-Nx for Vega, adding 21 CFR Part 11 audit logging and 90 Gb HiFi yield to benchtop long-read sequencing.

Vaibhavi M.
By Vaibhavi M.
Subject Matter Expert (B.Pharm) · Pharma Now
Aug 20, 20262 min read
Share
PacBio Launches SPRQ-Nx Chemistry on Vega Benchtop System with 21 CFR Part 11 Audit Logging
AI-assisted reporting
Reviewed by Vaibhavi M., Subject Matter Expert (B.Pharm) · Pharma Now
60/ 100
Trust score
Moderate confidence

For analytical development and QA teams weighing long-read sequencing as a release or characterization tool, PacBio's shipment of SPRQ-Nx chemistry for the Vega benchtop system this week introduces a compliance-relevant capability that previously required larger, higher-cost platforms. The update bundles higher yield, reduced DNA input requirements, and new user authentication and audit logging in SMRT Link, features that, combined with site-level validation procedures and access controls, are designed to support 21 CFR Part 11 compliance in regulated laboratory settings, including GMP-adjacent environments.

On the analytical side, SPRQ-Nx brings Vega into parity with PacBio's Revio system. Yield reaches up to 90 Gb of HiFi data per run at a consumable cost of approximately $995, while minimum DNA input drops to 500 ng, a fourfold reduction that broadens the sample types accessible to labs working with constrained starting material. Methylation detection now covers 5hmC alongside existing 5mC and 6mA calling, adding epigenomic resolution without additional workflow steps. New 2-hour and 4-hour run options make single-shift turnaround feasible for targeted amplicon workflows that previously required overnight sequencing.

For biopharma labs developing or validating sequence-based assays, the audit logging and user authentication additions in the companion software update represent the more operationally significant change. Regulated labs that previously could not qualify a benchtop long-read sequencer under their electronic records frameworks now have a documented path to evaluate Vega against their 21 CFR Part 11 validation requirements. The degree to which any site achieves compliance remains contingent on internal validation procedures, access policies, and quality system integration, PacBio's update provides the platform-level controls, not a turnkey compliance solution.

The PureTarget targeted sequencing workflow also scales with SPRQ-Nx, with multiplexing expanding to 96 samples per run. Per-sample consumable costs fall to approximately $90, with library prep adding roughly $80 per sample. For clinical research labs running repeat expansion or carrier screening panels at volume, the in-house economics shift meaningfully. Automation support via the Hamilton NGS STAR MOA system is available for sites operating at that throughput level, and the workflow is positioned as end-to-end from library prep through analysis.

Qualification teams evaluating Vega for regulated use should map the new SMRT Link audit logging capabilities against their site's existing 21 CFR Part 11 gap assessments before committing to assay development timelines.

Source: PacBio via pacb.com blog, 20 August 2026.

Read the original release ↗
TopicsNews
Vaibhavi M.
Written by
Vaibhavi M.
Subject Matter Expert (B.Pharm) · Pharma Now

Reporting on the science, business and regulation shaping the pharmaceutical industry.

Discussion

Loading discussion…

More from Pharma News

All stories →